ABSTRACT
A 3-year-old child was brought with fever, left parotid swelling and altered sensorium. Cultures from blood, pus and throat swab grew Burkholderia pseudomallei. A diagnosis of septicemic melioidosis with encephalopathy was made. She recovered following treatment with parenteral ceftazidime for 14 days, and 6 months of oral co-trimoxazole and amoxycillin- clavulanate. She is doing well on follow-up.
ABSTRACT
BACKGROUND: Despite the magnitude of the asthma problem, very little is known about the public perception about asthma. METHODS: This descriptive study was conducted to evaluate the knowledge, attitude and practice about the causation, treatment and prognosis of asthma amongst the parents of children with asthma. Subjects were parents of asthmatic children attending two exclusive paediatric hospitals at Chennai, India. A semi-structured pre-validated questionnaire, which included their general understanding on asthma, its triggers and management, was administered. RESULTS: One hundred parents of asthmatic children participated in this study. A diagnosis of asthma was accepted only by 39%, of which only three knew exactly what asthma means. Perception that asthma is contagious was observed by 26%, and 35% believed asthma to be a hereditary disease. Various dietary items were perceived as triggers. Most of the parents (62%) administered oral beta-agonist medication at home before proceeding to hospital, but majority were using them as cough medication. Only 13 were administering aerosol therapy at home. Nearly one-third of the parents opined that the disease might remit with advancing age. CONCLUSIONS: General awareness of asthma in the community is poor. Patient education programme should augment awareness, eliminate social stigma and misconcepts in the community regarding asthma. Knowledge about the prevailing perception in the community would be the first step in achieving this.
Subject(s)
Administration, Inhalation , Anti-Asthmatic Agents/therapeutic use , Asthma/diagnosis , Awareness , Female , Health Knowledge, Attitudes, Practice , Humans , India , Male , Parent-Child Relations , Patient Education as Topic/organization & administration , Surveys and Questionnaires , Severity of Illness IndexSubject(s)
Asthma/diagnosis , Body Height , Child , Child, Preschool , Humans , Peak Expiratory Flow RateABSTRACT
Drug therapy is used to prevent and control asthma, and also to reduce the frequency and severity of its exacerbations, and reverse airflow obstruction. Asthma medications are thus categorized into two general classes--bronchodilators (relievers) and anti-inflammatory drugs (preventers). Short acting beta2-agonists is the therapy of choice for relief of acute symptoms and prevention of exercise induced bronchospasm (EIB). Corticosteroids are the most potent and effective anti-inflammatory medication currently available. Inhaled form is used in the long-term control of asthma. Systemic corticosteroids are used to gain prompt control of the disease when initiating long-term therapy. Long acting bronchodilator used concomitantly with anti-inflammatory medications for long-term control of symptoms, especially nocturnal symptoms. Ipratropium bromide may provide some additive benefit to inhaled beta2-agonists in severe exacerbations. Sustained release theophylline is a mild to moderate bronchodilator used principally as adjuvant to inhaled corticosteroids for prevention of nocturnal asthma. Leukotriene modifiers may be considered as an alternative therapy to inhaled corticosteroids or cromolyn or nedocromil.